Glioblastoma News and Research

RSS

Glioblastoma is the most aggressive and malignant form of glioma, a type of primary brain cancer. Surgery is often used to treat gliomas, along with radiation. However, since surgery and radiation fail to cure the disease, doctors may turn to additional radiation or chemotherapy. In early stages glioblastoma tumors often grow without symptoms and therefore can become quite large before symptoms arise. When the tumor becomes symptomatic, tumor growth is usually very rapid and is accompanied by altered brain function, and if left untreated the disease becomes lethal. Although primary treatment is often successful in temporarily stopping the progression of the tumor, glioblastomas almost always recur and become lethal.

Multidisciplinary clinic uses neuropsychology to improve quality of life for cancer patients

Ken Kessler’s apparent depression and confusion were getting worse.

9 Mar 2023

Study finds two substances capable of inhibiting proliferation of glioblastoma cells

Glioblastoma is a malignant tumor of the central nervous system (brain or spinal cord) and one of the deadliest types of cancer.

7 Mar 2023

New way to carry drugs across the blood-brain barrier using nanoparticles

Brain tumors are notoriously hard to treat. One reason is the challenge posed by the blood-brain barrier, a network of blood vessels and tissue with closely spaced cells.

3 Mar 2023

Study highlights the interconnectedness of autoimmunity and cancer

In a recent study published in the journal Immunity, researchers reviewed the T cell response in cancer and autoimmunity to propose strategies for more effective immunotherapies.

15 Feb 2023

Case Western Reserve wins $3.03 million grant to advance novel MRI and software technology for brain tumor diagnosis

Most medical magnetic resonance imaging (MRI) scans are inherently qualitative, which can lead to subjective analysis and inconsistent conclusions.

8 Feb 2023

Blood pressure drug losartan can prevent immunotherapy-induced edema in glioblastoma patients

Patients with glioblastoma-;the deadliest type of primary brain tumor-;may potentially benefit from immunotherapy medications called immune checkpoint inhibitors that stimulate an immune response against cancer cells.

2 Feb 2023

Scientists Develop a Cancer Vaccine to Simultaneously Kill and Prevent Brain Cancer

Dual-action cell therapy engineered to eliminate established tumors and train the immune system to eradicate primary tumor and prevent cancer’s recurrence.

30 Jan 2023

Treatment to boost white blood cells may benefit patients with glioblastoma

A new study led by Washington University School of Medicine in St. Louis reveals at least one cause of low white blood cell counts in patients treated for glioblastoma and demonstrates a potential treatment strategy that improves survival in mice.

27 Jan 2023

Researchers receive $3.3 million NIH grant to study spectroscopic MRI for glioblastoma detection

Collaborative project with Emory University will refine groundbreaking spectroscopic MRI technology to make it easier to use.

25 Jan 2023

New tool for noninvasive imaging can help illuminate hard-to-access brain structures

Talk about a bright idea: Thanks to chemists at Rice University and Stanford University, lighting up the brain is no longer just a figure of speech.

17 Jan 2023

Researchers develop a computational model to accurately predict lethal brain tumor growth

Researchers at the University of Waterloo have created a computational model to predict the growth of deadly brain tumors more accurately.

16 Jan 2023

New cooling strategy could prevent the growth of glioblastoma

Cooling brain tumor cells to stop them from dividing without killing healthy cells extended the survival of glioblastoma (GBM) animal models dramatically in a study led by a UT Southwestern resident.

12 Jan 2023

Researchers show how liver cancer cells hijack circadian clock machinery to divide and spread

The most common type of liver cancer, hepatocellular carcinoma (HCC), is already the third leading cause of cancer-related deaths globally-;and cases are on the rise, both in the U.S. and worldwide.

6 Jan 2023

New dual-action, cancer-killing vaccine tested in an advanced mouse model of glioblastoma

Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS, PhD, at Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, investigators have developed a new cell therapy approach to eliminate established tumors and induce long-term immunity, training the immune system so that it can prevent cancer from recurring.

4 Jan 2023

Glioblastoma News and Research

Further Reading

Multidisciplinary clinic uses neuropsychology to improve quality of life for cancer patients

Study finds two substances capable of inhibiting proliferation of glioblastoma cells

New way to carry drugs across the blood-brain barrier using nanoparticles

Study highlights the interconnectedness of autoimmunity and cancer

Case Western Reserve wins $3.03 million grant to advance novel MRI and software technology for brain tumor diagnosis

Blood pressure drug losartan can prevent immunotherapy-induced edema in glioblastoma patients

Scientists Develop a Cancer Vaccine to Simultaneously Kill and Prevent Brain Cancer

Treatment to boost white blood cells may benefit patients with glioblastoma

Researchers receive $3.3 million NIH grant to study spectroscopic MRI for glioblastoma detection

New tool for noninvasive imaging can help illuminate hard-to-access brain structures

Researchers develop a computational model to accurately predict lethal brain tumor growth

New cooling strategy could prevent the growth of glioblastoma

Researchers show how liver cancer cells hijack circadian clock machinery to divide and spread

New dual-action, cancer-killing vaccine tested in an advanced mouse model of glioblastoma

Phase I clinical trial of PAC-1 in patients with end-stage cancers shows promising results

CARxALL clinical trial approved to evaluate CAR-T technology for patients with T-cell leukemia subtype

Using 3D patient tumor avatars to guide cancer treatment decisions

Phenotypic plasticity may allow cancer cells to evade standard therapy

Research: Patient's race may influence recommendations for surgical resection of brain tumors

Discovery of three new brain tumor subtypes could help to identify novel, effective therapies

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News